Boc-β-cyclohexyl-L-alanine dicyclohexylammonium salt
Need Assistance?
  • US & Canada:
    +
  • UK: +

Boc-β-cyclohexyl-L-alanine dicyclohexylammonium salt

* Please kindly note that our products are not to be used for therapeutic purposes and cannot be sold to patients.

Category
BOC-Amino Acids
Catalog number
BAT-007187
CAS number
37462-62-7
Molecular Formula
C14H25NO4·C12H23N
Molecular Weight
452.67
Boc-β-cyclohexyl-L-alanine dicyclohexylammonium salt
IUPAC Name
N-cyclohexylcyclohexanamine;(2S)-3-cyclohexyl-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoic acid
Synonyms
Boc-L-Cha-OH DCHA; Boc-3-cyclohexyl-L-alanine dicyclohexylammonium salt; (S)-N-α-tert-Butyloxycarbonyl-3-(cyclohexyl)alanine dicyclohexylamine; Boc L Cha OH DCHA
Appearance
White to off-white powder
Purity
≥ 99% (HPLC)
Storage
Store at 2-8 °C
InChI
InChI=1S/C14H25NO4.C12H23N/c1-14(2,3)19-13(18)15-11(12(16)17)9-10-7-5-4-6-8-10;1-3-7-11(8-4-1)13-12-9-5-2-6-10-12/h10-11H,4-9H2,1-3H3,(H,15,18)(H,16,17);11-13H,1-10H2/t11-;/m0./s1
InChI Key
GSGRQFGFPZQUQS-MERQFXBCSA-N
Canonical SMILES
CC(C)(C)OC(=O)NC(CC1CCCCC1)C(=O)O.C1CCC(CC1)NC2CCCCC2

Boc-β-cyclohexyl-L-alanine dicyclohexylammonium salt, a dipeptide derivative utilized in peptide synthesis and various biochemical applications, has a myriad of practical uses. Here are the key applications presented with a high degree of perplexity and burstiness:

Peptide Synthesis: Serving as a foundational element in peptide synthesis, Boc-β-cyclohexyl-L-alanine dicyclohexylammonium salt acts as a crucial building block. Its protected amino group enables seamless chain elongation without undesirable side reactions streamlining the creation of precise peptides for both research and therapeutic endeavors. This compound plays a pivotal role in the intricate dance of peptide assembly unlocking doors to new possibilities in biological exploration.

Drug Development: Positioned at the forefront of pharmaceutical innovation, this compound plays a vital role in crafting peptide-based drugs. By integrating Boc-β-cyclohexyl-L-alanine into peptides, researchers elevate stability binding affinity and bioavailability setting the stage for the development of potent peptide therapeutics with enhanced pharmacokinetics and efficacy. This synergistic fusion of chemistry and medicine heralds a new era of therapeutic potential and biotechnological advancement.

Molecular Biology Research: Delving into the realm of protein structure and function, Boc-β-cyclohexyl-L-alanine dicyclohexylammonium salt serves as a cornerstone in molecular biology studies. Incorporating this amino acid derivative into peptides enables the exploration of complex hydrophobic interactions and protein folding dynamics unveiling hidden insights into the behavior of proteins and their intricate interplay within biological systems. This molecular ballet sheds light on the inner workings of life itself unraveling the mysteries of biological complexity.

Enzyme Inhibition Studies: Unveiling the secrets of enzyme inhibition, this compound is a key player in the development of potent inhibitors. By integrating Boc-β-cyclohexyl-L-alanine into peptide sequences, researchers craft inhibitors that mimic natural substrates or transition states honing in on specific enzymes with surgical precision. This strategic approach to enzyme targeting holds the key to unlocking new vistas of therapeutic discovery offering a promising pathway towards novel treatments and pharmaceutical breakthroughs.

1. The formation of 2-hydroxypropylmercapturic acid from 1-halogenopropanes in the rat
E A Barnsley Biochem J. 1966 Aug;100(2):362-72. doi: 10.1042/bj1000362.
1. 2-Hydroxypropylmercapturic acid, i.e. N-acetyl-S-(2-hydroxypropyl)-l-cysteine, has been isolated, as the dicyclohexylammonium salt, from the urine of rats dosed with 1-bromopropane. 2. The formation of the same metabolite from 1-chloropropane, 1-iodopropane, 1,2-epoxypropane and 1-chloropropan-2-ol has been demonstrated by chromatographic examination of the urine excreted by rats after they had been dosed with these compounds. 3. (+)- and (-)-Dicyclohexylammonium 2-hydroxypropylmercapturate have been prepared by fractional crystallization of the mixture of isomers obtained by two methods: the reaction of 1,2-epoxypropane with l-cysteine followed by acetylation, and the reduction of 2-oxopropylmercapturic acid. 4. The following compounds have also been prepared: S-(3-hydroxypropyl)-l-cysteine, (+)- and (-)-S-(2-hydroxypropyl)-l-cysteine, dicyclohexylammonium 3-hydroxypropylmercapturate, (+)- and (-)-dicyclohexylammonium 2-hydroxy-1-methylethylmercapturate, and (+)- and (-)-dicyclohexylammonium 1-(ethoxycarbonyl)ethylmercapturate.
2. Induction of apoptosis in K562 cells by dicyclohexylammonium salt of hyperforin through a mitochondrial-related pathway
Jin-Yun Liu, Zhong Liu, Dong-Mei Wang, Man-Mei Li, Shao-Xiang Wang, Rui Wang, Jian-Ping Chen, Yi-Fei Wang, De-Po Yang Chem Biol Interact. 2011 Apr 25;190(2-3):91-101. doi: 10.1016/j.cbi.2011.02.026. Epub 2011 Mar 3.
Hyperforin is an abundant phloroglucinol-type constituent isolated from the extract of the flowering upper portion of the plant Hypericum perforatum L. The dicyclohexylammonium salt of hyperforin (DCHA-HF) has exhibited antitumor and antiangiogenic activities in various cancer cells. Here, the antitumor effects of DCHA-HF on the chronic myeloid leukemia K562 cell line were investigated for the first time. DCHA-HF exhibited dose- and time-dependent inhibitory activities against K562 cells, with IC(50) values of 8.6 and 3.2 μM for 48 h and 72 h of treatment, respectively, which was more effective than that of the hyperforin. In contrast, little cytotoxic activity was observed with DCHA-HF on HUVECs. DCHA-HF treatment resulted in induction of apoptosis as evidenced from DNA fragmentation, nuclear condensation and increase of early apoptotic cells by DAPI staining analysis, TUNEL assay and Annexin V-FITC/PI double-labeled staining analysis, respectively. Moreover, DCHA-HF elicited dissipation of mitochondrial transmembrane potential that commenced with the release of cytochrome c through down-regulation of expression of anti-apoptotic proteins and up-regulation of expression of pro-apoptotic proteins. DCHA-HF treatment induced activation of the caspase 3, 8, and 9 cascade and subsequent PARP cleavage, and DCHA-HF-induced apoptosis was significantly inhibited by caspase inhibitors. Treated cells were arrested at the G1 phase of the cell cycle and the expression of p53 and p27(Kip1), two key regulators related to cell cycle and apoptosis, was up-regulated. These results suggest that DCHA-HF inhibits K562 cell growth by inducing caspase-dependent apoptosis mediated by a mitochondrial pathway and arresting the cell cycle at the G1 phase. Therefore, DCHA-HF is a potential chemotherapeutic antitumor drug for chronic myeloid leukemia therapy.
3. Some metabolites of 1-bromobutane in the rabbit and the rat
S P James, D A Jeffery, R H Waring, P B Wood Biochem J. 1968 Oct;109(5):727-36. doi: 10.1042/bj1090727.
1. Rabbits and rats dosed with 1-bromobutane excrete in urine, in addition to butylmercapturic acid, (2-hydroxybutyl)mercapturic acid, (3-hydroxybutyl)mercapturic acid and 3-(butylthio)lactic acid. 2. Although both species excrete both the hydroxybutylmercapturic acids, only traces of the 2-isomer are excreted by the rabbit. The 3-isomer has been isolated from rabbit urine as the dicyclohexylammonium salt. 3. 3-(Butylthio)lactic acid is formed more readily in the rabbit; only traces are excreted by the rat. 4. Traces of the sulphoxide of butylmercapturic acid have been found in rat urine but not in rabbit urine. 5. In the rabbit about 14% and in the rat about 22% of the dose of 1-bromobutane is excreted in the form of the hydroxymercapturic acids. 6. Slices of rat liver incubated with S-butylcysteine or butylmercapturic acid form both (2-hydroxybutyl)mercapturic acid and (3-hydroxybutyl)mercapturic acid, but only the 3-hydroxy acid is formed by slices of rabbit liver. 7. S-Butylglutathione, S-butylcysteinylglycine and S-butylcysteine are excreted in bile by rats dosed with 1-bromobutane. 8. Rabbits and rats dosed with 1,2-epoxybutane excrete (2-hydroxybutyl)mercapturic acid to the extent of about 4% and 11% of the dose respectively. 9. The following have been synthesized: N-acetyl-S-(2-hydroxybutyl)-l-cysteine [(2-hydroxybutyl)mercapturic acid] and N-acetyl-S-(3-hydroxybutyl)-l-cysteine [(3-hydroxybutyl)mercapturic acid] isolated as dicyclohexylammonium salts, N-toluene-p-sulphonyl-S-(2-hydroxybutyl)-l-cysteine, S-butylglutathione and N-acetyl-S-butylcysteinyl-glycine ethyl ester.
Online Inquiry
Verification code
Inquiry Basket